Gilgamesh Pharmaceuticals’ psychedelic therapy has boasted a 94% depression remission rate after 29 days in a Phase IIa study. The trial (NCT06236880) investigated the efficacy, safety and ...

Naturally, don’t take this as any sign that the game will be out for our European PSN Store any time soon, but it’s encouraging to read that Square Enix producer Shinji Hashimoto says the ...

Even though FFIX has far more difficult sidequests, (especially the one involving Ozma) you receive a proportionate reward for your troubles. However, the reward here is so infinitesimal ...

AbbVie has agreed to pay $65 million on an option deal with start-up Gilgamesh Pharma, lining up rights to neuroplastogen compounds that can improve neuroplasticity - the ability of the brain to ...

FF9 trainer super cards, Super Cards AttackDefense Final Fantasy IX game, FF9 mod super cards, Final Fantasy 9 mod god mode, FFIX cheats no cooldown, FF9 trainer no cooldown, FF9 cheats unlimited gil, ...

FF9 trainer super cards, Super Cards AttackDefense Final Fantasy IX game, FF9 mod super cards, Final Fantasy 9 mod god mode, FFIX cheats no cooldown, FF9 trainer no cooldown, FF9 cheats unlimited gil, ...

“We have the biblical account and we can see how they intersect with the Bible… they’re talking about the same details…” Wayne emphasized that even though the Epic of Gilgamesh is often cited as being ...

Image credit: Black Salmon / Shutterstock. Gilgamesh Pharmaceuticals’ psychedelic therapy has boasted a 94% depression remission rate after 29 days in a Phase IIa study. The trial (NCT06236880) ...

New York-based neurosciences company Gilgamesh Pharmaceuticals yesterday announced Phase IIa results for GM-2505, a novel, rapid-acting 5-HT2A receptor agonist and 5-HT releaser in development for the ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...